Alfried Krupp Krankenhaus, ALS outpatient clinic

    Foundation year2016
    DirectorProf. Dr. med. Peter Berlit
    Principal investigatorDr. med. Torsten Grehl

    Our outpatient clinic at Alfried Krupp Krankenhaus, Essen, provides diagnosis and multidisciplinary care to around 500 patients with ALS and related motoneuron diseases. Our clinical research currently focuses on managed care, shared decison making (SDM) and palliative care. The ALS outpatient clinic cooperates with the ALS management platform AmbulanzPartner (www.ambulanzpartner.de).

    Contact Information

    AddressEssenAlfried-Krupp-Straße 2145131 Germany

    ContactDr. med. Torsten Grehl

    Website

    Restricted information

    Serving population
    1.000.0000 or more

    Patient resources

    Population based register
    Clinic based register
    Geographically matched controls
    Number of muscle samples
    0
    Number of skin samples
    80
    Number of spinal cord samples
    0
    Number of brain samples
    0
    Number of IPS cell samples
    5

    Banks

    TypeALS PatientsControlsOther
    DNA Bank
    370
    100
    0
    Serum Bank
    370
    100
    50

    Research activities

    Clinical management research
    Neuro epidemiology
    Neuro physiology
    Neuro imaging
    Neuro psychology
    Neuro pathology
    Genomics
    Transcriptomics
    Metabolomics

    Publication

    • Dorst, J., et al. (2015). “Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study.” J Neurol 262(4): 849-858.
    • Gerardo-Nava, J., et al. (2014). “Spinal cord organotypic slice cultures for the study of regenerating motor axon interactions with 3D scaffolds.” Biomaterials 35(14): 4288-4296.
    • Grehl, T. (2013). “[Diagnostics and therapy for amyotrophic lateral sclerosis].” Fortschr Neurol Psychiatr 81(10): 592-603;
    • Gerardo-Nava, J., et al. (2013). “Differential pattern of neuroprotection in lumbar, cervical and thoracic spinal cord segments in an organotypic rat model of glutamate-induced excitotoxicity.” J Chem Neuroanat 53: 11-17.
    • Synofzik, M., et al. (2012). “Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype.” Neurobiol Aging 33(12): 2949 e2913-2947.